OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus
Tao Jin, Xiangrui Fu, Ming Liu, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Tao Jin, Xiangrui Fu, Ming Liu, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus
Patryk Graczyk, Aleksandra Dach, Kamil Dyrka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5027-5027
Open Access | Times Cited: 11
Patryk Graczyk, Aleksandra Dach, Kamil Dyrka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5027-5027
Open Access | Times Cited: 11
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
Elina Khattab, Michaelia Kyriakou, Elena Leonidou, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 134-134
Open Access
Elina Khattab, Michaelia Kyriakou, Elena Leonidou, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 134-134
Open Access
Lipid metabolism reprogramming in cardiac fibrosis
Li-Chan Lin, Zhiyan Liu, Jing‐Jing Yang, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 2, pp. 164-175
Closed Access | Times Cited: 9
Li-Chan Lin, Zhiyan Liu, Jing‐Jing Yang, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 2, pp. 164-175
Closed Access | Times Cited: 9
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances
Xinping Chen, Xuan Li, Kexin Zhang, et al.
Clinical and Experimental Nephrology (2023) Vol. 28, Iss. 2, pp. 125-135
Closed Access | Times Cited: 8
Xinping Chen, Xuan Li, Kexin Zhang, et al.
Clinical and Experimental Nephrology (2023) Vol. 28, Iss. 2, pp. 125-135
Closed Access | Times Cited: 8
Diabetic Cardiomyopathy: What Clinicians Should Know
Hannah Smati, Yusuf Kamran Qadeer, Mario Rodríguez, et al.
The American Journal of Medicine (2024)
Closed Access | Times Cited: 2
Hannah Smati, Yusuf Kamran Qadeer, Mario Rodríguez, et al.
The American Journal of Medicine (2024)
Closed Access | Times Cited: 2
The latest emerging drugs for the treatment of diabetic cardiomyopathy
Minghao Li, Lin Liu, Chunyu Zhang, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 641-654
Closed Access | Times Cited: 1
Minghao Li, Lin Liu, Chunyu Zhang, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 641-654
Closed Access | Times Cited: 1
Roles of distinct nuclear receptors in diabetic cardiomyopathy
Yangyang Zheng, Yongji Xu, Li Ji, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Yangyang Zheng, Yongji Xu, Li Ji, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms
Jing Wang, Haojie Xue, Jinyu He, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Jing Wang, Haojie Xue, Jinyu He, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone
Alberto Ortíz, Roberto Alcázar Arroyo, Pedro Pablo Casado Escribano, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 6, pp. 519-531
Closed Access | Times Cited: 3
Alberto Ortíz, Roberto Alcázar Arroyo, Pedro Pablo Casado Escribano, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 6, pp. 519-531
Closed Access | Times Cited: 3
Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models
Luka Varda, Robert Ekart, Mitja Lainščak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9088-9088
Open Access
Luka Varda, Robert Ekart, Mitja Lainščak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9088-9088
Open Access
Sex-dependent effects of finerenone on hemostasis in normoglycemic and streptozotocin-induced diabetic mice
Natalia Bielicka, Misztal Tomasz, Chabielska Ewa, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115910-115910
Open Access | Times Cited: 1
Natalia Bielicka, Misztal Tomasz, Chabielska Ewa, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115910-115910
Open Access | Times Cited: 1
